Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05586347
Other study ID # hongweishi
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 22, 2022
Est. completion date September 30, 2022

Study information

Verified date October 2022
Source Nanjing First Hospital, Nanjing Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Postoperative cognitive dysfunction (POCD) is a common complication of cardiac surgery, mainly manifested as mental confusion, anxiety, personality change and memory impairment, which seriously affects the quality of life of patients after surgery.Attention should be paid to the protection of neurological function in patients undergoing cardiac surgery during perioperative period.Nicardipine can selectively act on coronary arteries and cerebral vessels, increase coronary artery and cerebral blood flow, relieve coronary heart disease angina pectoris, protect brain tissue.The cerebral protective effect of nicardipine on cardiovascular surgery under CPB deserves further clinical study.About 15-20% of cardiac output (CO) in healthy adults is allocated to the brain , and cerebral blood flow is supplied by bilateral internal carotid artery (ICA) and vertebral artery (VA), among which ICA provides about 70%-80% of cerebral perfusion flow .However, the location of the internal carotid artery is superficial, the anatomical variation is less, and the ultrasonic Doppler technique is portable and simple to measure. It may be of certain clinical value to use the ultrasonic detection technology to quickly evaluate the cerebral perfusion during the perioperative period, and to early detect and avoid the intraoperative brain function injury.


Description:

Patients who were scheduled to undergo open-heart surgery under cardiopulmonary bypass were randomly divided into nicardipine group (group N) and normal saline control group (group C) by the digital table method. Group N was pumped with nicardipine 0.2-0.5μg/(kg·min) after CPB, while group C was given the same volume of normal saline. The basic hemodynamic parameters, rScO2, BIS, maximum systolic velocity of internal carotid artery (PSV-ICA), end-diastolic velocity of internal carotid artery (EDV-ICA), diameter of internal carotid artery (D-ICA), internal carotid artery blood flow (Q-ICA) and cerebral blood flow ratio (CBF/CO) were observed and recorded in the two groups at each time point ), cerebrovascular resistance (CVR) and the concentration of NSE, a biomarker of brain injury.The following hypothesis is proposed: during CPB, pump nicardipine can dilate the internal carotid artery and cerebral arterioles, increase cerebral blood flow, improve cerebral oxygen supply, and reduce the risk of postoperative cognitive dysfunction(POCD).


Recruitment information / eligibility

Status Completed
Enrollment 64
Est. completion date September 30, 2022
Est. primary completion date September 22, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years to 80 Years
Eligibility Inclusion Criteria: - 1: Age 60-80 2: ASA ?-?, NYHA?-?, EF =50% 3: CABG under cardiopulmonary bypass Exclusion Criteria: - 1: Patients who had second heart surgery 2: Patients with intellectual disabilities, deafness or other impairments in normal communication 3: Previous neurosurgical procedures and history of cerebral infarction 4: cancer 5: Patients with moderate to severe carotid artery stenosis before operation 6: Patients with obvious abnormal liver and kidney function affecting drug metabolism 7: Patients taking psychotropic drugs 8: Alcoholism, drug addiction, drug dependence 9: The cardiopulmonary bypass time was greater than 120 minutes

Study Design


Intervention

Drug:
Nicardipine
Nicardipine 0.2-0.5µg/(kg·min) was infused at the beginning of CPB.
Other:
normal saline
It has the same capacity as group N?

Locations

Country Name City State
China Hongwei Shi Nanjing Jiangsu

Sponsors (1)

Lead Sponsor Collaborator
Nanjing First Hospital, Nanjing Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Internal carotid blood flow Blood flow through the internal carotid artery was measured per minute by ultrasound Before induction of anesthesia
Primary Internal carotid blood flow Blood flow through the internal carotid artery was measured per minute by ultrasound Surgical skin excision
Primary Internal carotid blood flow Blood flow through the internal carotid artery was measured per minute by ultrasound During cardiopulmonary bypass
Primary Internal carotid blood flow Blood flow through the internal carotid artery was measured per minute by ultrasound After cardiopulmonary bypass
Secondary Regional cerebral oxygen After the forehead skin is degreased and dried with alcohol,attach the NIRS probe. Before induction of anesthesia
Secondary Regional cerebral oxygen After the forehead skin is degreased and dried with alcohol,attach the NIRS probe. Surgical skin excision
Secondary Regional cerebral oxygen After the forehead skin is degreased and dried with alcohol,attach the NIRS probe. During cardiopulmonary bypass
Secondary Regional cerebral oxygen After the forehead skin is degreased and dried with alcohol,attach the NIRS probe. After cardiopulmonary bypass
Secondary Mini-mental State Examination scale score Illiteracy group (no education) less than 17 points, primary school group (education =6 years) less than 20 points, secondary school or above group (education > 6 years) less than 24 points, the above is normal. 1 day before surgery
Secondary Mini-mental State Examination scale score Illiteracy group (no education) less than 17 points, primary school group (education =6 years) less than 20 points, secondary school or above group (education > 6 years) less than 24 points, the above is normal. 7 days after surgery.
Secondary Neuron specific endase 3ml arterial blood was collected and centrifuged. The plasma was stored in a refrigerator at -70? for measurement, and the concentration of NSE was determined by ELISA. Before induction of anesthesia
Secondary Neuron specific endase 3ml arterial blood was collected and centrifuged. The plasma was stored in a refrigerator at -70? for measurement, and the concentration of NSE was determined by ELISA. 2 hours after surgery.
See also
  Status Clinical Trial Phase
Completed NCT04084301 - Impact of Cardiopulmonary Bypass Flow on Renal Oxygenation, Blood Flow and Tubular Injury N/A
Completed NCT04062396 - Comparison of Remowell 2 and Inspire on Delirium and Cognitive Dysfunction N/A
Completed NCT02518087 - Increased Adsorption Membranes During Cardiopulmonary Bypass N/A
Recruiting NCT01231776 - Acupuncture Improves Sleep in Patients Undergoing Cardiopulmonary Bypass N/A
Completed NCT00747331 - Fenoldopam and Splanchnic Perfusion During Cardiopulmonary Bypass Phase 4
Terminated NCT00176657 - The Use of HEMOBAG to Salvage Blood After Cardiac Surgery Phase 2
Completed NCT00161733 - Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery Phase 3
Completed NCT05525195 - Influence of Preop Fibrinogen on Blood in Pediatric Cardiac Surgery
Completed NCT05537168 - Bayesian Networks in Pediatric Cardiac Surgery
Completed NCT04238806 - Desflurane,Brain Natriuretic Peptide and Cardiac Surgery N/A
Completed NCT00981474 - Cerebral Autoregulation Monitoring During Cardiac Surgery N/A
Recruiting NCT05588011 - Influence of Oxygenator Selection on Platelet Function and Rotational Thromboelastometry Following Cardiopulmonary Bypass N/A
Completed NCT02566733 - Minto Model in Effect Site Mode for Target-Controlled Infusion of Remifentanil During Cardiopulmonary Bypass Phase 4
Terminated NCT00385450 - Cardiopulmonary Bypass-Induced Lymphocytopenia and the Potential Effects of Protease Inhibitor Phase 1
Completed NCT00246740 - Protection of the Heart With Doxycycline During Coronary Artery Bypass Grafting Phase 2
Not yet recruiting NCT05075265 - Pharmacokinetics of Methadone in Adults Undergoing Cardiac Surgery With Extracorporeal Circulation
Recruiting NCT04296071 - Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
Completed NCT05579964 - The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot Phase 2/Phase 3
Active, not recruiting NCT04133740 - Oxygenation Targets in Cardiac Surgery Patients - a Before-and-after Study Phase 4
Completed NCT05033236 - Platelets and Complement Activation in Coronary Artery Bypass Graft Surgery (CABG)